News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
424,218 Results
Type
Article (48217)
Company Profile (89)
Press Release (375906)
Multimedia
Podcasts (37)
Webinars (14)
Section
Business (117537)
Career Advice (1340)
Deals (16300)
Drug Delivery (60)
Drug Development (50367)
Employer Resources (94)
FDA (8109)
Job Trends (9301)
News (192042)
Policy (15006)
Tag
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (2670)
Academic (1)
Accelerated approval (19)
Adcomms (11)
Allergies (76)
Alliances (33989)
ALS (120)
Alzheimer's disease (1392)
Antibody-drug conjugate (ADC) (194)
Approvals (8295)
Artificial intelligence (376)
Autoimmune disease (103)
Automation (20)
Bankruptcy (94)
Best Places to Work (7364)
BIOSECURE Act (10)
Biosimilars (65)
Biotechnology (53)
Bladder cancer (81)
Brain cancer (47)
Breast cancer (413)
Cancer (3263)
Cardiovascular disease (219)
Career advice (1131)
Career pathing (28)
CAR-T (190)
CDC (23)
Celiac Disease (1)
Cell therapy (491)
Cervical cancer (19)
Clinical research (41503)
Collaboration (1318)
Compensation (158)
Complete response letters (23)
COVID-19 (2006)
CRISPR (75)
C-suite (546)
Cystic fibrosis (121)
Data (4243)
Decentralized trials (2)
Denatured (16)
Depression (84)
Diabetes (285)
Diagnostics (4092)
Digital health (24)
Diversity (7)
Diversity, equity & inclusion (24)
Drug discovery (203)
Drug pricing (86)
Drug shortages (6)
Duchenne muscular dystrophy (141)
Earnings (45311)
Editorial (37)
Employer branding (14)
Employer resources (84)
Events (52710)
Executive appointments (625)
FDA (9938)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (3)
Frontotemporal dementia (14)
Funding (1018)
Gene editing (139)
Generative AI (33)
Gene therapy (380)
GLP-1 (525)
Government (2526)
Grass and pollen (2)
Guidances (322)
Healthcare (11439)
HIV (40)
Huntington's disease (23)
IgA nephropathy (45)
Immunology and inflammation (117)
Immuno-oncology (37)
Indications (67)
Infectious disease (2163)
Inflammatory bowel disease (122)
Inflation Reduction Act (6)
Influenza (72)
Intellectual property (159)
Interviews (265)
IPO (7845)
IRA (32)
Job creations (2189)
Job search strategy (964)
JPM (25)
Kidney cancer (8)
Labor market (59)
Layoffs (291)
Leadership (15)
Legal (2598)
Liver cancer (45)
Longevity (10)
Lung cancer (414)
Lymphoma (258)
Machine learning (35)
Management (30)
Manufacturing (457)
MASH (114)
Medical device (6280)
Medtech (6305)
Mergers & acquisitions (9059)
Metabolic disorders (651)
Multiple sclerosis (107)
NASH (12)
Neurodegenerative disease (219)
Neuropsychiatric disorders (47)
Neuroscience (2247)
Neurotech (1)
NextGen: Class of 2026 (3581)
Non-profit (4237)
Now hiring (45)
Obesity (246)
Opinion (179)
Ovarian cancer (134)
Pain (108)
Pancreatic cancer (143)
Parkinson's disease (224)
Partnered (26)
Patents (276)
Patient recruitment (293)
Peanut (34)
People (35681)
Pharmaceutical (23)
Pharmacy benefit managers (9)
Phase 1 (13088)
Phase 2 (17746)
Phase 3 (13871)
Pipeline (3705)
Policy (166)
Postmarket research (1854)
Preclinical (7164)
Press Release (65)
Prostate cancer (176)
Psychedelics (27)
Radiopharmaceuticals (182)
Rare diseases (528)
Real estate (3841)
Recruiting (38)
Regulatory (12363)
Reports (33)
Research institute (2581)
Resumes & cover letters (190)
Rett syndrome (16)
RNA editing (6)
RSV (40)
Schizophrenia (108)
Series A (143)
Series B (95)
Service/supplier (10)
Sickle cell disease (69)
Special edition (17)
Spinal muscular atrophy (129)
Sponsored (30)
Startups (2293)
Stomach cancer (3)
Supply chain (48)
Tariffs (33)
The Weekly (21)
Vaccines (689)
Venture capital (43)
Weight loss (127)
Women's health (48)
Worklife (8)
Date
Today (8)
Last 7 days (287)
Last 30 days (1215)
Last 365 days (17849)
2026 (1530)
2025 (18171)
2024 (21219)
2023 (24576)
2022 (34288)
2021 (36293)
2020 (33462)
2019 (27934)
2018 (21089)
2017 (19469)
2016 (19442)
2015 (22909)
2014 (17246)
2013 (15241)
2012 (15213)
2011 (15869)
2010 (14709)
Location
Africa (584)
Alabama (72)
Alaska (3)
Arizona (122)
Arkansas (5)
Asia (25934)
Australia (4938)
California (6228)
Canada (1991)
China (689)
Colorado (263)
Connecticut (294)
Delaware (171)
Europe (61663)
Florida (1023)
Georgia (206)
Hawaii (1)
Idaho (27)
Illinois (496)
India (44)
Indiana (331)
Iowa (19)
Japan (309)
Kansas (61)
Kentucky (21)
Louisiana (15)
Maine (20)
Maryland (796)
Massachusetts (4578)
Michigan (203)
Minnesota (268)
Mississippi (3)
Missouri (82)
Montana (25)
Nebraska (17)
Nevada (57)
New Hampshire (36)
New Jersey (1961)
New Mexico (27)
New York (1924)
North Carolina (990)
North Dakota (6)
Northern California (3011)
Ohio (190)
Oklahoma (14)
Oregon (18)
Pennsylvania (1209)
Puerto Rico (6)
Rhode Island (29)
South America (639)
South Carolina (24)
South Dakota (1)
Southern California (2477)
Tennessee (88)
Texas (1012)
United States (23087)
Utah (171)
Vermont (1)
Virginia (181)
Washington D.C. (56)
Washington State (596)
West Virginia (2)
Wisconsin (72)
Wyoming (1)
424,218 Results for "scleroderma research foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Indero CRO and the World Scleroderma Foundation Announce Strategic Collaboration to Advance Early Therapeutic Intervention in Systemic Sclerosis
January 28, 2026
·
4 min read
Business
The Scleroderma Research Foundation Appoints Dr. Gregory Gordon as Chief Medical Officer
The Scleroderma Research Foundation announces the appointment of Gregory Gordon, MD, JD as its first Chief Medical Officer.
January 25, 2024
·
5 min read
Biotech Bay
The Scleroderma Research Foundation Announces the Launch of the CONQUEST Trial Platform and IND Clearance
The Scleroderma Research Foundation, the nation’s largest non-profit funder of scleroderma research, announced that the FDA has cleared its Investigational New Drug application to launch the CONQUEST clinical trial platform and begin enrolling patients.
December 19, 2023
·
7 min read
Press Releases
Lung Cancer Research Foundation Announces 2026 Requests for Proposals
January 13, 2026
·
4 min read
Press Releases
Lung Cancer Research Foundation Announces Additional 2025 Scientific Research Grant Awards
January 7, 2026
·
8 min read
Business
The Scleroderma Research Foundation (SRF) Announces Second Partnership for Conquest Trial Platform
The Scleroderma Research Foundation, the nation’s largest non-profit funder of scleroderma research, announced that Boehringer Ingelheim, a leading research-driven biopharmaceutical company, will contribute an experimental agent to CONQUEST, a highly innovative clinical trial platform created by the SRF.
October 3, 2023
·
4 min read
Press Releases
ConcertAI and Foundation Medicine Integrate Genomic and Clinical Data to Transform Translational Research and Efficient Drug Development
January 12, 2026
·
5 min read
Press Releases
Lung Cancer Research Foundation Announces 2025 Scientific Research Grant Awards
December 3, 2025
·
5 min read
Press Releases
The Reeve Foundation and Spinal Research Award New Grants to Advance Traumatic Spinal Cord Injury Treatments
January 7, 2026
·
7 min read
Press Releases
One Genomics and CiRA Foundation Announce Strategic Research Collaboration to Advance Precision Genome Engineering
January 9, 2026
·
2 min read
1 of 42,422
Next
